AzTrials
AzTrials

Alveolar Bone LossSTRNCT03077880

Influence of Thickness of the Peri-implant Soft Tissue on Marginal Bone Remodeling

An observational study of Alveolar Bone Loss, run by International Piezosurgery Academy at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this observational study is the evaluation of marginal bone remodeling after surgical implant placement, correlating the gingival thickness with the bone resorption rate. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Alveolar Bone Loss
What is being tested?
intra-operatory measurement during implant placement
Type of treatment
Surgery or procedure
How many people
100 participants
Where
1 siteItaly
Study dates
15 Jan 2017to 15 Sep 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: patients referred to the centers

Who may be able to join

  • indications for intervention of implant placement in posterior mandible (premolar / molar region) based on a careful diagnosis and treatment plan;
  • presence of a residual osseous crest with a minimum of 7 mm surgical height, and thickness of at least 6 mm at the level of the programmed implant site;
  • the bone crest must be healed (at least 6 months after the loss / extraction of the element corresponding tooth);
  • absence of regenerated bone;
  • plaque index of less than 25% and bleeding index lower than 20%;
  • bucco-lingual width of the attached gingiva ≥ 4 mm;
Show all 10Show fewer
  • insertion torque plant inserito≥35 N / cm;
  • patient age> 18 years;
  • patients should be able to examine and understand the study protocol;
  • informed consent.

Who cannot join

  • acute myocardial infarction in the last two months;
  • blood coagulation disorders not compensated;
  • uncontrolled diabetes (HbA1c> 7.5%);
  • radiation therapy of the district head / neck in the last 24 months;
  • immunocompromised patients (HIV infection or chemotherapy) within the last 5 years);
  • present or past treatment with intravenous bisphosphonates;
Show all 9Show fewer
  • psychological or psychiatric diseases;
  • alcohol or drug abuse;
  • Smoking of local exclusion criteria are the diagnosis of periodontal disease acute or chronic, a previous history of periodontal disease, the presence of regenerated bone, lingual bucco- size of keratinized tissue <4 mm, insertion torque less than 35 N / cm.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Piezosurgery Academy

    Parma, 43100

Other trials in Italy

About this study

Official title: Influence Of Thickness Of the Peri-implant Soft Tissue On Marginal Bone Remodeling Around Bone Level Implant: A Multicenter Observational Clinical Study

The aim of this observational study is the evaluation of marginal bone remodeling after surgical implant placement, correlating the gingival thickness with the bone resorption rate.

Read the detailed description

The present study was designed as a multicenter prospective clinical trial. Five clinical centers will treat patients through the placement of a single dental implant. The fixtures will be prosthetic loaded three months after placement and will be acquired periapical radiographs at each timepoint (base-two months-three-months-6 months-12 months). For every inserted implants the experimental parameters will be collected for the following 2 years.

Surgical procedure. All patients will receive antibiotic prophylaxis with 2 g of amoxicillin one hour before surgery. Crestal incision is performed under local anesthesia with articaine 4% with epinephrine, taking care to preserve the keratinized tissue. With the help of a periosteal elevator, it will be set up carefully buccal flap total thickness, and the vertical thickness of the soft tissue will be measured with a labeled probe every 1.0 mm. If the vertical thickness of the soft tissue will be 2 mm or less, it will be considered thin. If mucosal thickness will be greater than 2 mm, it will be considered thick. After measurement, the lingual flap will be raised to full-thickness, and will be prepared the site for implant placement. The implant site will be at least 1.5 mm from the tooth / teeth adjacent, and must be surrounded by at least 1 mm of bone is buccal to lingual. With a platform switching facility a millimeter will be placed below the level of the bone crest with a one-stage approach as per the manufacturer's recommendations. After insertion, it will be screwed a healing abutment, and the flaps will be sutured without tension with interrupted sutures 4/0. Patients of both groups will be instructed to disinfect the site through a rinse twice a day for a week for 1 minute with 0.12% chlorhexidine digluconate. Patients will be advised to avoid chewing on the operated site and cleaning the healing abutments with an ultra soft toothbrush. After 2 months of healing, it will be evaluated clinical stability and the radiographic appearance of the plants. All plants will be rehabilitated by the prosthetist with single screwed restorations. After the prosthetic treatment, patients will receive oral hygiene instruction and will be monitored through calls to ensure periodontal health (Bleeding on Probing <20% and Plaque Index <25%) throughout the study period.

Radiographic evaluation Intraoral radiographs will be captured in high-resolution mode with a film, customized support from a jig polyvinylsiloxane, using the technique of parallel rays. Intraoral radiographs will be acquired after implant placement (baseline-assessment of inclusion fairness), after 2 months of healing (osseointegration rating), after insertion of the crown (3 months-adaptation assessment of the restoration prosthetic), after 6 months (early loading of evaluation) and after a year of recovery (of the medium-term load rating). The number of intraoral radiographs will be the same which normally is carried out in the course of an implant-prosthetic rehabilitation. The images will be obtained in such a way that the implant-abutment interface is clearly visible. Measurements of bone level will be performed by a blinded central reader using a dedicated program at 20 times magnification. Before the calculation of the crestal bone changes, the RVG images will be calibrated with the implant diameter. bone loss will be calculated by comparing the radiographs at baseline with the radiographs obtained during follow-up visits. The system board and the first contact radiographic bone-implant will be selected as reference points to calculate bone loss. The average of the mesial and distal measurements will be recorded for each implant.

Being tested
intra-operatory measurement during implant placement
Keywords
implant insertion, bone resorption, soft tissue
Medical subject headings
Alveolar Bone Loss, Bone Resorption

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • intra-operatory measurement during implant placementProcedure or surgery

    mucoperiosteal flap, soft tissue thickness measurement, implant insertion

Study groups in NCT03077880
Study groupRoleWhat they receive
thin soft tissuefull thickness thin mucosal soft tissue at the periodontal probe measured intra-operatory measurement during implant placement
Receives: Procedure: intra-operatory measurement during implant placement
thick soft tissuefull thickness thick mucosal soft tissue at the periodontal probe measured intra-operatory measurement during implant placement
Receives: Procedure: intra-operatory measurement during implant placement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. peri-implant bone resorption

    radiological assessment of change in the peri-implant bone crest

    Measured: from baseline to twelve months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Mar 2017
  2. Study start15 Jan 2017
  3. Primary completion15 Jul 2018
  4. Study completion15 Sep 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03077880
Sponsor's protocol ID
STR
Acronym
STR
Status last verified
Mar 2019
First submitted
25 Jan 2017
Last updated
20 Mar 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Sicilia A, Quirynen M, Fontolliet A, Francisco H, Friedman A, Linkevicius T, Lutz R, Meijer HJ, Rompen E, Rotundo R, Schwarz F, Simion M, Teughels W, Wennerberg A, Zuhr O. Long-term stability of peri-implant tissues after bone or soft tissue augmentation. Effect of zirconia or titanium abutments on peri-implant soft tissues. Summary and consensus statements. The 4th EAO Consensus Conference 2015. Clin Oral Implants Res. 2015 Sep;26 Suppl 11:148-52. doi: 10.1111/clr.12676.

    PubMed 26385628

Questions about this trial

What is this clinical trial studying?

An observational study of Alveolar Bone Loss, run by International Piezosurgery Academy at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

peri-implant bone resorption (time frame: from baseline to twelve months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03077880, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Mar 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in